Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.

Jan 2, 2025 · The FDA signed off on 55 new drugs in 2024, down from 60-plus in 2023.

Jan 2, 2025 · After a compounding group sued the FDA over its decision to declare the shortage of tirzepatide over, Eli Lilly is looking to muscle in on the case.

Apr 15, 2024 · There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...

Jan 29, 2024 · Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each ...

Nov 6, 2024 · On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed to win the U.S. | Over his first term, Donald Trump advocated for ...

Dec 23, 2024 · BMS said it will present detailed results at an upcoming medical conference. The company’s chief of immunology, cardiovascular and neuroscience development, Roland Chen, M.D., added that BMS ...

Jan 3, 2025 · Evaluate first pegged Roche to become the top drugmaker by prescription sales in its 2024 preview, estimating the Swiss firm would generate pharma revenue for the year approaching $54 billion.. At ...

Jan 2, 2025 · Zolgensma as an intravenous infusion has been approved in the U.S. for children under 2 years with SMA since 2019. The intrathecal version injects the gene therapy directly into the spinal cord ...

Oct 28, 2024 · Taking a closer look at the data, Apellis’ pegcetacoplan led to a statistically significant and clinically meaningful 68.1% proteinuria reduction at the 24-week mark in the late-stage VALIANT ...